Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-KhAZowiE
September 28, 2023jessica-sacher
Clinical trials Phage therapy Biotech news

The first patient in Armata Pharmaceuticals’ newest trial has been treated. This is part of the Phase 2a portion of their diSArm study, which evaluates the potential treatment of S. aureus bacteremia.

Loading ...
No comments yet. Be the first to comment!